CIK 0001850270 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 532,535 shares (conversion)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Conversion Director acquired 757,162 shares (conversion)
- 8-K Event Material agreement
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale Chief Regulatory Officer sold 16,412 shares at $2.50 ($41,030)
- 144 Insider Sale of Securities
Page 6 of 21 · 406 filings